Phase I study of DNX-2401 (delta-24-RGD) oncolytic adenovirus: replication and immunotherapeutic effects in recurrent malignant glioma

  1. Lang, F.F.
  2. Conrad, C.
  3. Gomez-Manzano, C.
  4. Alfred Yung, W.K.
  5. Sawaya, R.
  6. Weinberg, J.S.
  7. Prabhu, S.S.
  8. Rao, G.
  9. Fuller, G.N.
  10. Aldape, K.D.
  11. Gumin, J.
  12. Vence, L.M.
  13. Wistuba, I.
  14. Rodriguez-Canales, J.
  15. Villalobos, P.A.
  16. Dirven, C.M.F.
  17. Tejada, S.
  18. Valle, R.D.
  19. Alonso, M.M.
  20. Ewald, B.
  21. Peterkin, J.J.
  22. Tufaro, F.
  23. Fueyo, J.
Journal:
Journal of Clinical Oncology

ISSN: 1527-7755 0732-183X

Year of publication: 2018

Volume: 36

Issue: 14

Pages: 1419-1427

Type: Article

DOI: 10.1200/JCO.2017.75.8219 GOOGLE SCHOLAR

Sustainable development goals